Ministério da Saúde
Secretaria de Políticas de Saúde
Coordenação Nacional de DST e Aids

 

Brazilian manufacture

   Exclusively manufactured by multinational companies

 

Costs of antiretroviral drugs in Brazil (1996-2000)

Chart 1: Antiretrovirals currently produced in Brazil

Drug

Unit price in  $US(1)  Nominal variation% 1st period-00
1996 1997 1998 1999 2000 (2) 96- 97 97- 98 98- 99 99 - 00 Período Variação
ZIDOVUDINE CAP. 100mg 0,56 0,53 0,45 0,21 0,18 -5,98 -15,29 -52,88 -13,09 96 - 00 -67,39
ZIDOVUDINE ORAL.SOL 10mg/ml Fl.200ml 10,22 9,17 8,47 6,30 4,55 -10,28 -7,61 -25,63 -27,76 96 - 00 -55,47
ZIDOVUDINe SUSP.INJ.10mg/ml Fl 20ml 13,40 11,93 11,07 2,46 2,15 -11,03 -7,14 -77,76 -12,83 96 - 00 -83,98
ZIDOVUDINE+LAMIVUDINE TAB.300+150mg # # 3,38 2,01 0,72 - - -40,37 -64,48 98 - 00 -78,82
DIDANOSINE TAB. 25mg 0,52 0,41 0,26 0,23 0,19 -21,09 -36,69 -9,95 -16,39 96 - 00 -62,39
DIDANOSINE TAB. 100mg 1,85 1,39 1,02 0,76 0,51 -24,73 -26,33 -25,72 -32,84 96 - 00 -72,34
DIDANOSINE POWDER FOR ORAL.SOL FL.4g (3) # # 60,19 37,81 38,84 - - -37,18 2,72 98 - 00 -35,47
ZALCITABINE TAB. 0,75mg 1,55 1,08 0,58 0,18 0,08 -30,06 -46,03 -69,51 -56,42 96 - 00 -94,99
LAMIVUDINE TAB. 150mg 2,90 2,70 2,39 1,51 0,83 -6,74 -11,60 -36,73 -45,34 96 - 00 -71,49
LAMIVUDINE ORAL SOL. 10mg/ml Fl.240ml # 45,57 31,18 12,05 12,76 - -31,58 -61,36 5,94 97 - 00 -71,99
STAVUDINE  CAP.30mg (3) # 1,75 1,03 0,46 0,21 - -41,04 -54,98 -53,73 97 - 00 -87,72
STAVUDINE  CAP.40mg (3) # 2,32 1,02 0,64 0,28 - -55,98 -37,18 -56,54 97 - 00 -87,98
  MEAN

-72,50

# ARV not made avaliable by Ministry of Health

Source:
National STD/Aids Programme/Secretariat for Health Policies
Strategic Programmes Directorate/Executive Secretariat

Notes:
(1)
ARV acquired in R$ and converted into $US, at the average exchange rate for year in question except for year 2000 (mean value for Jan/2000)
(2)  preliminary data
(3) Data  estimated by Far-Manguinhos, year 2000


 

Chart 2: Imported  Antiretrovirals

Drugs Unit price in $US  Nominal Variation % 1st period - 00*
1996 1997 1998 1999 2000 (1) 96- 97 97- 98 98- 99 99 - 00 Period Variation
INDINAVIR CAP. 400 mg(2) 2,00 2,00 1,94 1,91 1,72 0,00 -3,00 -1,34 -10,14 96 - 00 -14,00
RITONAVIR CAP.100mg 0,90 0,90 0,88 0,88 0,88 0,00 -2,15 0,00 0,00 96 - 00 -2,15
RITONAVIR ORAL SOL 80mg/ml Fl.240ml (3)

#

222,41 168,94 168,94 168,94 - -24,04 0,00 0,00 97 - 00 -24,04
SAQUINAVIR CAP.200mg 1,31 1,31 1,19 1,19 0,75 0,00 -9,39 0,00 -36,97 96 - 00 -42,89
NELFINAVIR CAP.250mg # # 1,53 1,45 1,36 - - -5,23 -6,21 98 - 00 -11,11
NELFINAVIR POWDER FOR ORAL SUSP FL.7,2g  # # 52,40 52,40 - - - 0,00 - 98 -99 0,00
EFAVIRENZ CAP. 200mg # # # 2,32 2,32 - - - 0,00 99 - 00 0,00
EFAVIRENZ CAP. 100mg # # # 1,3 1,3 - - - 0,00 99 - 00 0,00
EFAVIRENZ CAP. 50MG # # # 0,65 0,65 - - - 0,00 99 - 00 0,00
NEVIRAPINE Tab .200mg(2) # # 3,04 3,02 2,63 - - -0,66 -12,91 98 - 00 -13,49
DELAVIRDINE Tab.100mg # # 0,48 0,48 - - - 0,00 - 98 - 99 0,00
   MEAN

-9,79

* except nelfinavir powder and  delavirdine

# ARV not made available by the Ministry of Health

Source:
National STD/Aids Programme/Secretariat for Health Policies
Strategic Programmes Directorate/Executive Secretariat

Notes:
(1)
Preliminary Data
(2) produced by  Far-Manguinhos, from year 2000
(3) Price reduction caused by interruption of tablet production and need by the company to  equalize prices of substituted capsules and solution prices

08/apr/2000